STAT+: Pharma is only ‘inching forward’ in boosting access to medicines in low-income countries

Like the proverbial tortoise, a new analysis finds that while the pharmaceutical industry is taking steps to provide access to its medicines, it is doing so at a slower pace than is needed for lower-income countries.

The most notable sign of progress is in the R&D planning stages, as more drug makers are thinking ahead about access issues. Specifically, eight companies are developing approaches for systematically ensuring all of their R&D projects are positioned to increase access in low-income countries after product launches.

Continue to STAT+ to read the full story…

Related Articles

Responses

Your email address will not be published. Required fields are marked *

Receive the latest news

Subscribe To Our Weekly Newsletter

Get notified about chronicles from TreatMyBrand directly in your inbox